A joint venture between the biotechnology company BIOCAD and Shanghai Pharmaceuticals Holding has announced the enrollment of the first patient in a trial of...
In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year efficacy study of the Russian...